LANCASTER HOUSE CONSULTING & DIAGNOSTIC & SURGICAL LIMITED Financials
- Company number
- 05475953CopyCopy
- Registered office
- The Exchange, 5 Bank Street, Bury BL9 0DN
- Incorporated
- 09/06/2005
Company snapshot
- Status
- Active
- Employees
- 0 (2025)
- Latest financial data
- 2025
- Accounts type
- Total Exemption Full
Financial highlights
Latest reported figures. Okredo holds filed data for 2021–2025.
Net Assets
5.42%vs 20242024: £12.58M
Total Assets
-76.15%vs 20242024: £12.66M
Cash in Bank
41.66%vs 20242024: £1.74M
Total Liabilities
206.21%vs 20242024: £87.77K
Employees
0vs 20242024: 0
In 2025, LANCASTER HOUSE CONSULTING & DIAGNOSTIC & SURGICAL LIMITED reported net assets of £13.26M. The same filing shows total assets of £3.02M, cash in bank of £2.47M and total liabilities of £268.75K. Reported headcount was 0 in 2025. Total Assets fell from £12.66M in 2024 to £3.02M in 2025 (-76.15%). Okredo holds filed figures for 2021–2025; the table below lists every reported indicator by year. See every reported indicator by year.
Financial performance
Pick a measure to see how it has moved across the reported years, with the year-on-year change beneath it.
Net Assets
5.42%from £12.58M in 2024Year-on-year change
Net Assets as filed for 2021–2025. Every figure in this chart is also in the financial history table.
3-year financial trend (2023–2025)
How the figures LANCASTER HOUSE CONSULTING & DIAGNOSTIC & SURGICAL LIMITED filed moved across the three reported years 2023, 2024 and 2025 — measured end to end rather than year on year.
Net Assets
+9.5%vs 2023+4.7% a year compound (CAGR)
Cash in Bank
+206%vs 2023+74.9% a year compound (CAGR)
Total Assets
-75.5%vs 2023-50.5% a year compound (CAGR)
Total Liabilities
+8.2%vs 2023+4% a year compound (CAGR)
Employees
-100%vs 2023-19Biggest increase
Cash in Bank+206%
£806.08K in 2023 to £2.47M in 2025
Biggest decrease
Employees-100%
19 in 2023 to 0 in 2025
LANCASTER HOUSE CONSULTING & DIAGNOSTIC & SURGICAL LIMITED's filings pull in both directions between 2023 and 2025. The steepest rise came in cash in bank, pointing to a more liquid cash position, set against a fall in employee numbers, pointing to a smaller workforce. See the full year-by-year figures.
Ratios from the filed figures
Calculated from LANCASTER HOUSE CONSULTING & DIAGNOSTIC & SURGICAL LIMITED's own reported amounts, each shown against the year it was derived from — nothing here is estimated or industry-averaged.
- Net assets to total assets
- 438.93%2025
- Reported net assets divided by reported total assets, for the latest year both were filed. Shows how much of the asset base is not financed by liabilities.
- Liabilities to total assets
- 8.90%2025
- Total liabilities divided by reported total assets, for the latest year both were available. Shows how much of the asset base is funded by obligations.
- Cash to liabilities
- 917.80%2025
- Reported cash in bank divided by total liabilities for the same year. Shows what share of outstanding obligations the reported cash balance would cover.
- Cash to total assets
- 81.66%2025
- Reported cash in bank divided by reported total assets, for the latest year both were filed.
Financial history
Every indicator Okredo tracks, year by year.
Reported financial indicators for LANCASTER HOUSE CONSULTING & DIAGNOSTIC & SURGICAL LIMITED by year. Amounts are as filed; a dash means the figure was not reported for that year.
| Indicator | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Net Assets£ | 9.78M | 10.94M | 12.10M | 12.58M | 13.26M |
| Total Assets£ | 11.23M | 11.88M | 12.35M | 12.66M | 3.02M |
| Cash in Bank£ | 4.20M | 2.66M | 806.08K | 1.74M | 2.47M |
| Total Liabilities£ | 1.45M | 942.24K | 248.46K | 87.77K | 268.75K |
| Employees | 22 | 24 | 19 | 0 | 0 |
LANCASTER HOUSE CONSULTING & DIAGNOSTIC & SURGICAL LIMITED financials: frequently asked questions
Answered from this company's own filed figures.
Yes. Okredo holds filed figures for LANCASTER HOUSE CONSULTING & DIAGNOSTIC & SURGICAL LIMITED covering 2021–2025, across 5 reported indicators. The most recent reported year is 2025.
LANCASTER HOUSE CONSULTING & DIAGNOSTIC & SURGICAL LIMITED reported net assets of £13.26M for 2025. That compares with £12.58M in 2024, a change of 5.42%.
LANCASTER HOUSE CONSULTING & DIAGNOSTIC & SURGICAL LIMITED reported total assets of £3.02M for 2025. That compares with £12.66M in 2024, a change of -76.15%.
LANCASTER HOUSE CONSULTING & DIAGNOSTIC & SURGICAL LIMITED reported cash in bank of £2.47M for 2025. That compares with £1.74M in 2024, a change of 41.66%.
LANCASTER HOUSE CONSULTING & DIAGNOSTIC & SURGICAL LIMITED reported 0 employees in 2025, compared with 0 in 2024.
Between 2023 and 2025, LANCASTER HOUSE CONSULTING & DIAGNOSTIC & SURGICAL LIMITED's net assets rose by 9.5%, cash in bank rose by 206%, total assets fell by 75.5% and total liabilities rose by 8.2%. Net assets compounded at 4.7% a year across the two years to 2025, from £12.10M to £13.26M. Reported headcount went from 19 in 2023 to 0 in 2025 (-19).
Okredo holds reported figures for the years 2021, 2022, 2023, 2024, 2025. Where an indicator was not reported for a given year, the financial history table shows a dash rather than a value.